Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

Clinical trial NCT05861453 · COMPLETED

Trial details

NCT number: NCT05861453
Sponsor: Afimmune
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2024-01-10
Primary completion: 2026-01-21
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.